End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.19 CNY | +0.57% | -2.67% | -6.21% |
05-15 | China Grants Drug Registration for Huiyu Pharma's Two Injectables | MT |
04-26 | Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 1.49B 206M 16.25B | Sales 2023 | 927M 128M 10.09B | Capitalization | 6.41B 886M 69.74B |
---|---|---|---|---|---|
Net income 2022 | 249M 34.42M 2.71B | Net income 2023 | 140M 19.35M 1.52B | EV / Sales 2022 | 2.73 x |
Net cash position 2022 | 2.53B 349M 27.5B | Net cash position 2023 | 2.14B 296M 23.29B | EV / Sales 2023 | 4.6 x |
P/E ratio 2022 |
26.4
x | P/E ratio 2023 |
45.8
x | Employees | 1,669 |
Yield 2022 |
1.51% | Yield 2023 |
1.41% | Free-Float | 39.27% |
1 day | +0.57% | ||
1 week | -2.67% | ||
Current month | -1.11% | ||
1 month | +16.69% | ||
3 months | +17.47% | ||
6 months | -7.74% | ||
Current year | -6.21% |
Managers | Title | Age | Since |
---|---|---|---|
Zhao Ding
CEO | Chief Executive Officer | 39 | 11/10/10 |
Lan Gao
DFI | Director of Finance/CFO | 53 | 13/10/19 |
Li Na Ma
BRD | Director/Board Member | 48 | 30/04/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Li Na Ma
BRD | Director/Board Member | 48 | 30/04/22 |
Lan Gao
DFI | Director of Finance/CFO | 53 | 13/10/19 |
Zhao Ding
CEO | Chief Executive Officer | 39 | 11/10/10 |
Date | Price | Change | Volume |
---|---|---|---|
20/05/24 | 14.19 | +0.57% | 927,112 |
17/05/24 | 14.11 | +1.07% | 799,705 |
16/05/24 | 13.96 | -0.64% | 917,145 |
15/05/24 | 14.05 | -1.40% | 1,337,019 |
14/05/24 | 14.25 | -2.26% | 1,721,199 |
End-of-day quote Shanghai S.E., May 19, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-6.21% | 828M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- 688553 Stock